Securing Paxlovid's inventory for 120,000 people

There is a temporary shortage due to increased prescriptions

Paxlovid's inventory in Korea is about 120,000 people, it said on the 11th.

 

The response is to the point that there is no shortage of prescriptions for confirmed patients, which has been on the rise recently, and that there is no inventory of Paxlovid at front-line pharmacies or medical sites.

 

More and more patients want Paxlovid due to the explosion of COVID-19 confirmed patients.

 

Contrary to the quarantine authorities' explanation that the stock of treatments is sufficient, complaints are growing that local pharmacies and other sites do not have them in stock.

 

First controller Lee Ki-il (CDSCHQ) of Central Disaster and Safety Counters (CDSCHQ), disclosed the inventory and introduction status of Paxlovid in response to this point.

 

He said on the 8th that an additional 45,000 people of Paxlovid were introduced and a total of 163,000 people have been introduced so far.

 

He explains that the amount of Paxlovid prescribed so far is about 40,000 people, and the domestic inventory is about 120,000 people.

 

Regarding the shortage of treatments at the site, the quarantine authorities explained that they recently expanded prescription medical institutions to actively utilize oral drugs.

 

As of the 8th, it is interpreted that oral prescriptions may increase to upper general hospitals, general hospitals, and mental hospitals, which may temporarily lead to a shortage of supplies.

 

The quarantine authorities said they would try to provide sufficient supply of additional Paxlovid inventory in the future.

 

When looking at the introduction and usage, about inventory for 120,000 people was prescribed on the 9th, and for 4,472 people were prescribed on the 10th.

 

Paxlovid have been expanded to actively utilize treatments.

 

If the introduction of additional supplies is confirmed, it will be released later, he said.